Use of ketamine in acute cases of suicidality

Innovations in Clinical Neuroscience

Volumn 12, Issue 1-2, 2015, Pages 29-31

  Lee, Jae ^a   Narang, Puneet ^b   Enja, Manasa ^c   Lippmann, Steven ^c  

^a Regions Hospital ^*  (United States)

^b REGIONS HOSPITAL   (United States)

^c University of Louisville School of Medicine   (United States)

Author keywords

Emergency room; Ketamine; Suicidal behavior; Suicidal ideation; Suicidal prevention; Suicidality

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT RECEPTOR; KETAMINE; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ARTICLE; CLINICAL TRIAL (TOPIC); DEPRESSION; DISSOCIATIVE DISORDER; HUMAN; HYPERTENSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUICIDAL BEHAVIOR; SUICIDAL IDEATION; TACHYCARDIA;

EID: 84938079466     PISSN: 21588333     EISSN: 21588341     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kessler R, Chiu W, Demler O, Walters E. Prevalence, severity, and comorbidity of 12-month DSMIV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62(6):617–627
2. Grant B, Stinson F, Hasin D, et al. Prevalence, correlates, and comorbidity of bipolar disorder I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66(10):1205–1215
3. Qin P, Nordentoft M. Suicide risk in relation to psychiatric hospitalization: evidence based on longitudinal registers. Arch Gen Psychiatry. 2005;62(4):427–432
4. Post R, Leverich G, Altshuler L, et al. Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany. Int Clin Psychopharmacol. 2011;26(2):96–106
5. Machado-Vieira R, Salvadore G, Luckenbaugh D, et al. Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder. J Clin Psychiatry. 2008;69(6):946–958
6. Price R, Iosifescu D, Murrough J, et al. Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression. Depress Anxiety. 2014;31(4):335–343
7. Zarate C, Brutsche N, Ibrahim L, et al. Replication of ketamine’s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biologic Psychiatry. 2012;71(11):939–946
8. Stahl S. Mechanism of action of ketamine. CNS spectrum. 2013;18(4):171–174
9. Browne C, Lucki I. Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants. Frontiers Pharmacol. 2013;4(12):1–18
10. Caddy C, Giaroli G, White T, et al. Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and metaanalysis of efficacy. Therapeut Adv Psychopharmacol. 2014;4(2):75–99
11. Goforth H, Holsinger T. Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy. J ECT. 2007;23(1):23–25
12. Chilukuri H, Reddy N, Pathapati R, et al. Acute antidepressant effects of intramuscular versus intravenous ketamine. Ind J Psychologic Med. 2014;36(1):71–76
13. Berman R, Cappiello A, Anand A, et al. Antidepressant effects of ketamine in depressed patients. Biologic Psychiatry. 2000;47(4):351–354
14. DiazGranados N, Ibrahim L, Brutsche N, et al. Rapid resolution of suicidal ideation after a single infusion of an NMDA antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry. 2010;71(12):1605–1611
15. Price R, Iosifescu D, Murrough J, et al. Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression. Depress Anxiety. 2014;31(4):335–343
16. Larkin G, Beautrais A. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Neuropsychopharmacol. 2011;14(8):1127–1131
17. Kashani P, Yousefian S, Amini A, et al. Effect of intravenous ketamine in suicidal ideation in emergency department patients. Emergency. 2014;2(1):36-39
18. De Gioannis A, De Leo D. Oral ketamine augmentation for chronic suicidality in treatment-resistant depression. Aust N Z J Psychiatry. 2014;47:710–727
19. Diamond P, Farmery A, Atkinson S, et al. Ketamine infusions for treatment-resistant depression: a series of 28 patients treated weekly or twice weekly in the ECT clinic. J Psychopharmacol. 2014 Apr 3;28(6):536-544
20. Luckenbaugh D, Niciu M, Ionescu D, et al. Do dissociative side effects of ketamine mediate its antidepressant effects? J Affect Disord. 2013;159(4):56–61
21. Weiner A, Vieira L, McKay C, Bayer M. Ketamine abusers presenting to the emergency department: a case series. J Emergency Med. 2000;18(4):447–451.